Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56


Hepatitis B virus activity in untreated hepatitis B e antigen-negative human immunodeficiency virus-hepatitis B virus co-infected patients from sub-Saharan Africa.

Boyd A, Kouamé MG, Houghtaling L, Moh R, Gabillard D, Maylin S, Abdou Chekaraou M, Delaugerre C, Anglaret X, Eholié SP, Danel C, Zoulim F, Lacombe K; ANRS 12136 Temprano and ANRS 12240 VarBVA studies.

Trans R Soc Trop Med Hyg. 2019 Aug 1;113(8):437-445. doi: 10.1093/trstmh/trz021.


Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study.

Semenova T, Nemoz B, Thibault V, Lagathu G, Duverlie G, Brochot E, Trimoulet P, Payan C, Vallet S, Henquell C, Chevaliez S, Bouvier-Alias M, Maylin S, Roque-Afonso AM, Izquierdo L, Lunel-Fabiani F, Marcellin P, Morand P, Leroy V, Larrat S.

Epidemiol Infect. 2019 Jan;147:e234. doi: 10.1017/S0950268819001225.


A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection.

Salpini R, Battisti A, Colagrossi L, Di Carlo D, Fabeni L, Piermatteo L, Cerva C, Lichtner M, Mastroianni C, Marignani M, Maylin S, Delaugerre C, Morisco F, Coppola N, Marrone A, Angelico M, Sarmati L, Andreoni M, Perno CF, Ceccherini-Silberstein F, Svicher V.

J Viral Hepat. 2019 Jul;26(7):846-855. doi: 10.1111/jvh.13101. Epub 2019 May 14.


Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa.

Boyd A, Moh R, Maylin S, Abdou Chekaraou M, Mahjoub N, Gabillard D, Anglaret X, Eholié SP, Danel C, Delaugerre C, Zoulim F, Lacombe K; ANRS 12240 VarBVA study.

Liver Int. 2019 Feb;39(2):280-289. doi: 10.1111/liv.13975. Epub 2018 Oct 17.


Poor Sensitivity of Commercial Rapid Diagnostic Tests for Hepatitis B e Antigen in Senegal, West Africa.

Seck A, Ndiaye F, Maylin S, Ndiaye B, Simon F, Funk AL, Fontanet A, Takahashi K, Akbar SMF, Mishiro S, Bercion R, Vray M, Shimakawa Y.

Am J Trop Med Hyg. 2018 Aug;99(2):428-434. doi: 10.4269/ajtmh.18-0116. Epub 2018 May 31.


Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

Colagrossi L, Hermans LE, Salpini R, Di Carlo D, Pas SD, Alvarez M, Ben-Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Lepej SZ, Weis N, Yalcinkaya T, Boucher CAB, Wensing AMJ, Perno CF, Svicher V; HEPVIR working group of the European Society for translational antiviral research (ESAR).

BMC Infect Dis. 2018 Jun 1;18(1):251. doi: 10.1186/s12879-018-3161-2.


Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.

Boyd A, Moh R, Maylin S, Abdou Chekaraou M, Mahjoub N, Gabillard D, Anglaret X, Eholié SP, Delaugerre C, Danel C, Zoulim F, Lacombe K; ANRS 12240 VarBVA study.

J Viral Hepat. 2018 Oct;25(10):1121-1131. doi: 10.1111/jvh.12914. Epub 2018 May 9.


Hepatitis A infections in men who have sex with men using HIV PrEP in Paris.

Penot P, Colombier MA, Maylin S, Molina JM.

BMJ Case Rep. 2018 Jan 11;2018. pii: bcr-2017-222248. doi: 10.1136/bcr-2017-222248.


Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.

Kouamé GM, Boyd A, Moh R, Badje A, Gabillard D, Ouattara E, Ntakpe JB, Emième A, Maylin S, Chekaraou MA, Eholié SP, Zoulim F, Lacombe K, Anglaret X, Danel C; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 12136 Temprano and ANRS 12240 VarBVA Study Groups.

Clin Infect Dis. 2018 Jan 6;66(1):112-120. doi: 10.1093/cid/cix747.


Hepatitis B Virus-Hepatitis D Virus mother-to-child co-transmission: A retrospective study in a developed country.

Sellier PO, Maylin S, Brichler S, Berçot B, Lopes A, Chopin D, Pogliaghi M, Munier AL, Delcey V, Simoneau G, Evans J, Gordien E, Simon F, Bergmann JF.

Liver Int. 2018 Apr;38(4):611-618. doi: 10.1111/liv.13556. Epub 2017 Sep 12.


Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.

Maylin S, Feghoul L, Salmona M, Herda A, Mercier-Delarue S, Simon F, Legoff J.

J Med Virol. 2017 Nov;89(11):2003-2010. doi: 10.1002/jmv.24889. Epub 2017 Aug 1.


Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.

Sellier PO, Maylin S, Berçot B, Chopin D, Lopes A, Simoneau G, Evans J, Delcey V, Bénifla JL, Simon F, Bergmann JF.

Eur J Gastroenterol Hepatol. 2017 Mar;29(3):259-263. doi: 10.1097/MEG.0000000000000793.


Baseline HBsAg and HBcrAg titres allow peginterferon-based 'precision medicine' in HBeAg-negative chronic hepatitis B patients.

Martinot-Peignoux M, Lapalus M, Maylin S, Boyer N, Castelnau C, Giuily N, Pouteau M, Moucari R, Asselah T, Marcellin P.

J Viral Hepat. 2016 Nov;23(11):905-911. doi: 10.1111/jvh.12565. Epub 2016 Jul 4.


Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.

Ducancelle A, Pivert A, Bertrais S, Boursier J, Balan V, Veillon P, le Guillou-Guillemette H, Thibault V, Castelain S, Roquebert B, Coste-Burel M, Mackiewicz V, Schvoerer E, Larrat S, Maylin S, Alain S, Loustaud-Ratti V, Gordien E, Gozlan J, Brodard V, Chevaliez S, Calès P, Lunel-Fabiani F.

J Gastroenterol Hepatol. 2016 Oct;31(10):1750-1756. doi: 10.1111/jgh.13338.


First next-generation sequencing full-genome characterization of a hepatitis C virus genotype 7 divergent subtype.

Salmona M, Caporossi A, Simmonds P, Thélu MA, Fusillier K, Mercier-Delarue S, De Castro N, LeGoff J, Chaix ML, François O, Simon F, Morand P, Larrat S, Maylin S.

Clin Microbiol Infect. 2016 Nov;22(11):947.e1-947.e8. doi: 10.1016/j.cmi.2016.07.032. Epub 2016 Aug 8.


Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients.

Boyd A, Piroth L, Maylin S, Maynard-Muet M, Lebossé F, Bouix C, Lascoux-Combe C, Mahjoub N, Girard PM, Delaugerre C, Carrat F, Lacombe K, Miailhes P.

J Viral Hepat. 2016 Dec;23(12):1017-1026. doi: 10.1111/jvh.12581. Epub 2016 Aug 3.


Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients.

Boyd A, Lacombe K, Lavocat F, Maylin S, Miailhes P, Lascoux-Combe C, Delaugerre C, Girard PM, Zoulim F.

J Hepatol. 2016 Oct;65(4):683-691. doi: 10.1016/j.jhep.2016.05.014. Epub 2016 May 19.


First HSV-1 non primary genital herpes in two patients.

Fouéré S, Chaine B, Maylin S, Minier M, Vallée P, Scieux C, Lassau F, Legoff J, Janier M.

J Clin Virol. 2016 May;78:108-10. doi: 10.1016/j.jcv.2016.03.018. Epub 2016 Mar 22.


First description of past Hepatitis B Virus infection acute reactivation occurring in a Human Immunodeficiency Virus infected patient as manifestation of immune reconstitution inflammatory syndrome.

Lepelletier C, Salmona M, Berçot B, Maylin S, Sellier PO.

J Infect Chemother. 2016 Jul;22(7):490-4. doi: 10.1016/j.jiac.2016.01.004. Epub 2016 Feb 23.


Short article: Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.

Sellier PO, Schnepf N, Amarsy R, Maylin S, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Simoneau G, Evans J, Souak S, Matheron S, Benifla JL, Simon F, Bergmann JF.

Eur J Gastroenterol Hepatol. 2016 Mar;28(3):328-32. doi: 10.1097/MEG.0000000000000559.


Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.

Boyd A, Maylin S, Moh R, Mahjoub N, Gabillard D, Eholié SP, Danel C, Anglaret X, Zoulim F, Girard PM, Delaugerre C, Lacombefor K; ANRS 12240 VarBVA study.

J Gastroenterol Hepatol. 2016 Mar;31(3):634-44. doi: 10.1111/jgh.13156.


Identifying patients infected with hepatitis B virus in sub-Saharan Africa: potential for misclassification.

Boyd A, Maylin S, Moh R, Gabillard D, Menan H, Mahjoub N, Danel C, Anglaret X, Eholié SP, Girard PM, Zoulim F, Delaugerre C, Lacombe K; ANRS 12240 VarBVA study.

Diagn Microbiol Infect Dis. 2015 Nov;83(3):248-51. doi: 10.1016/j.diagmicrobio.2015.07.009. Epub 2015 Jul 18.


HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study.

Bekondi C, Zanchi R, Seck A, Garin B, Giles-Vernick T, Gody JC, Bata P, Pondy A, Tetang SM, Ba M, Ekobo CS, Rousset D, Sire JM, Maylin S, Chartier L, Njouom R, Vray M.

BMC Infect Dis. 2015 Jul 12;15:267. doi: 10.1186/s12879-015-1000-2.


Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).

Hermans LE, Svicher V, Pas SD, Salpini R, Alvarez M, Ben Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Weis N, Yalcinkaya T, Lepej SZ, Perno C, Boucher CA, Wensing AM; HEPVIR Working Group of the European Society for Translational Antiviral Research.

J Infect Dis. 2016 Jan 1;213(1):39-48. doi: 10.1093/infdis/jiv363. Epub 2015 Jul 1.


Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin.

Larrat S, Vallet S, David-Tchouda S, Caporossi A, Margier J, Ramière C, Scholtes C, Haïm-Boukobza S, Roque-Afonso AM, Besse B, André-Garnier E, Mohamed S, Halfon P, Pivert A, LeGuillou-Guillemette H, Abravanel F, Guivarch M, Mackiewicz V, Lada O, Mourez T, Plantier JC, Baazia Y, Alain S, Hantz S, Thibault V, Gaudy-Graffin C, Bouvet D, Mirand A, Henquell C, Gozlan J, Lagathu G, Pronier C, Velay A, Schvoerer E, Trimoulet P, Fleury H, Bouvier-Alias M, Brochot E, Duverlie G, Maylin S, Gouriou S, Pawlotsky JM, Morand P.

J Clin Microbiol. 2015 Jul;53(7):2195-202. doi: 10.1128/JCM.03633-14. Epub 2015 Apr 29.


Short-term spontaneous fluctuations of HBV DNA levels in a Senegalese population with chronic hepatitis B.

Maylin S, Sire JM, Mbaye PS, Simon F, Sarr A, Evra ML, Fall F, Daveiga J, Diallo A, Debonne JM, Chartier L, Vray M.

BMC Infect Dis. 2015 Mar 25;15:154. doi: 10.1186/s12879-015-0881-4.


Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.

Boyd A, Moh R, Gabillard D, le Carrou J, Danel C, Anglaret X, Eholié SP, Maylin S, Delaugerre C, Zoulim F, Girard PM, Lacombe K; ANRS 12240 VarBVA study.

Antivir Ther. 2015;20(6):643-54. doi: 10.3851/IMP2959. Epub 2015 Apr 8.


Sicca syndrome and dementia in a patient with hepatitis C infection: a case report with unusual bifocal extrahepatic manifestations.

Khonsari RH, Maylin S, Nicol P, Martinot-Peignoux M, Créange A, Duyckaerts C, Bertolus C.

J Maxillofac Oral Surg. 2015 Mar;14(Suppl 1):388-92. doi: 10.1007/s12663-014-0632-x. Epub 2014 Jun 5.


Hepatitis B virus (HBV) status of children born to HIV/HBV co-infected women in a French hospital: a cross-sectional study.

Sellier P, Schnepf N, Amarsy R, Maylin S, Coutellier M, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Ricbourg A, Dolores-Moreno AM, Simoneau G, Evans J, Souak S, Matheron S, Mouly S, Benifla JL, Simon F, Bergmann JF.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19632. doi: 10.7448/IAS.17.4.19632. eCollection 2014.


Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications.

Boyd A, Gozlan J, Maylin S, Delaugerre C, Peytavin G, Girard PM, Zoulim F, Lacombe K.

Hepatology. 2014 Aug;60(2):497-507. doi: 10.1002/hep.27182. Epub 2014 Jun 20.


Untreated highly viraemic pregnant women from Asia or sub-Saharan Africa often transmit hepatitis B virus despite serovaccination to newborns.

Sellier P, Maylin S, Amarsy R, Mazeron MC, Larrouy L, Haïm-Boukobza S, Lopes A, Moreno MD, Ricbourg A, Simoneau G, Magnier JD, Mercier-Delarue S, Delcey V, Evans J, Cambau E, Barranger E, Simon F, Bergmann JF.

Liver Int. 2015 Feb;35(2):409-16. doi: 10.1111/liv.12561. Epub 2014 Apr 28.


Loss of anti-hepatitis C virus antibodies following therapeutic sustained virological response in a HIV co-infected patient.

Maylin S, de Verdière NC, Salmona M, Simon F, Delaugerre C.

J Infect Chemother. 2014 Jun;20(6):384-6. doi: 10.1016/j.jiac.2014.01.006. Epub 2014 Mar 6.


Use of hepatitis B surface and "e" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV.

Boyd A, Maylin S, Gozlan J, Delaugerre C, Simon F, Girard PM, Lacombe K.

Liver Int. 2015 Mar;35(3):795-804. doi: 10.1111/liv.12521. Epub 2014 Mar 31.


Failure of fourth-generation enzyme immunoassay in HIV screening and plasma HIV-1 RNA detection in recent high-risk behavior.

Maylin S, Fouéré S, Simon F, Delaugerre C.

Intervirology. 2014;57(1):49-51. doi: 10.1159/000355315. Epub 2013 Oct 18.


Clinical evaluation of BioPlex 2200 HIV Ag-Ab, an automated screening method providing discrete detection of HIV-1 p24 antigen, HIV-1 antibody, and HIV-2 antibody.

Salmona M, Delarue S, Delaugerre C, Simon F, Maylin S.

J Clin Microbiol. 2014 Jan;52(1):103-7. doi: 10.1128/JCM.02460-13. Epub 2013 Oct 23.


Higher specificity of nucleic acid sequence-based amplification isothermal technology than of real-time PCR for quantification of HIV-1 RNA on dried blood spots.

Mercier-Delarue S, Vray M, Plantier JC, Maillard T, Adjout Z, de Olivera F, Schnepf N, Maylin S, Simon F, Delaugerre C.

J Clin Microbiol. 2014 Jan;52(1):52-6. doi: 10.1128/JCM.01848-13. Epub 2013 Oct 16.


Effect of tenofovir with and without interferon on hepatitis D virus replication in HIV-hepatitis B virus-hepatitis D virus-infected patients.

Boyd A, Miailhes P, Brichler S, Scholtès C, Maylin S, Delaugerre C, Chevallier-Queyron P, Gordien E, Girard PM, Lacombe K.

AIDS Res Hum Retroviruses. 2013 Dec;29(12):1535-40. doi: 10.1089/AID.2013.0008. Epub 2013 Sep 24.


Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization.

Rey-Cuille MA, Njouom R, Bekondi C, Seck A, Gody C, Bata P, Garin B, Maylin S, Chartier L, Simon F, Vray M.

Pediatr Infect Dis J. 2013 Oct;32(10):1110-5. doi: 10.1097/INF.0b013e31829be401.


Multicenter quality control of hepatitis C virus protease inhibitor resistance genotyping.

Vallet S, Larrat S, Laperche S, Le Guillou-Guillemette H, Legrand-Abravanel F, Bouchardeau F, Pivert A, Henquell C, Mirand A, André-Garnier E, Giordanengo V, Lagathu G, Thibault V, Scholtes C, Schvoerer E, Gaudy-Graffin C, Maylin S, Trimoulet P, Brochot E, Hantz S, Gozlan J, Roque-Afonso AM, Soussan P, Plantier JC, Charpentier C, Chevaliez S, Colson P, Mackiewicz V, Aguilera L, Rosec S, Gouriou S, Magnat N, Lunel-Fabiani F, Izopet J, Morand P, Payan C, Pawlotsky JM.

J Clin Microbiol. 2013 May;51(5):1428-33. doi: 10.1128/JCM.03032-12. Epub 2013 Feb 20.


Quantification of hepatitis B e antigen between Elecsys HBeAg and Architect HBeAg assays among patients infected with hepatitis B virus.

Maylin S, Boyd A, Martinot-Peignoux M, Delaugerre C, Bagnard G, Lapalus M, Zoulim F, Lavocat F, Marcellin P, Simon F, Girard PM, Lacombe K.

J Clin Virol. 2013 Apr;56(4):306-11. doi: 10.1016/j.jcv.2012.12.022. Epub 2013 Jan 28.


Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients.

Maylin S, Boyd A, Lavocat F, Gozlan J, Lascoux-Combe C, Miailhes P, Lassel L, Delaugerre C, Girard PM, Zoulim F, Lacombe K.

AIDS. 2012 May 15;26(8):939-49. doi: 10.1097/QAD.0b013e328352224d.


Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised.

Maylin S, Stephan R, Molina JM, Peraldi MN, Scieux C, Nicand E, Simon F, Delaugerre C.

J Clin Virol. 2012 Apr;53(4):346-9. doi: 10.1016/j.jcv.2012.01.001. Epub 2012 Jan 30.


Transforming self- the experience of living with another's heart: A systematic review of qualitative evidence on adult heart transplantation.

Godfrey C, Maylin S, Ross-White A.

JBI Libr Syst Rev. 2012;10(56 Suppl):1-10. No abstract available.


Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus.

Maylin S, Boyd A, Delaugerre C, Zoulim F, Lavocat F, Simon F, Girard PM, Lacombe K.

Clin Vaccine Immunol. 2012 Feb;19(2):242-8. doi: 10.1128/CVI.05454-11. Epub 2011 Dec 21.


Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy.

Maylin S, Laouénan C, Martinot-Peignoux M, Panhard X, Lapalus M, Nicolas-Chanoine MH, Bedossa P, Asselah T, Marcellin P.

J Clin Virol. 2012 Jan;53(1):43-7. doi: 10.1016/j.jcv.2011.09.029. Epub 2011 Nov 17.


Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays.

Sire JM, Vray M, Merzouk M, Plantier JC, Pavie J, Maylin S, Timsit J, Lascoux-Combe C, Molina JM, Simon F, Delaugerre C.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):239-43. doi: 10.1097/QAI.0b013e3182099891.


Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis.

Cardoso AC, Moucari R, Figueiredo-Mendes C, Ripault MP, Giuily N, Castelnau C, Boyer N, Asselah T, Martinot-Peignoux M, Maylin S, Carvalho-Filho RJ, Valla D, Bedossa P, Marcellin P.

J Hepatol. 2010 May;52(5):652-7. doi: 10.1016/j.jhep.2009.12.028. Epub 2010 Mar 4.


Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.

Martinot-Peignoux M, Stern C, Maylin S, Ripault MP, Boyer N, Leclere L, Castelnau C, Giuily N, El Ray A, Cardoso AC, Moucari R, Asselah T, Marcellin P.

Hepatology. 2010 Apr;51(4):1122-6. doi: 10.1002/hep.23444.


Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C.

Martinot-Peignoux M, Khiri H, Leclere L, Maylin S, Marcellin P, Halfon P.

J Clin Virol. 2009 Nov;46(3):216-21. doi: 10.1016/j.jcv.2009.08.011. Epub 2009 Sep 12.


Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4.

Moucari R, Ripault MP, Martinot-Peignoux M, Voitot H, Cardoso AC, Stern C, Boyer N, Maylin S, Nicolas-Chanoine MH, Vidaud M, Valla D, Bedossa P, Marcellin P.

Gut. 2009 Dec;58(12):1662-9. doi: 10.1136/gut.2009.185074. Epub 2009 Aug 10.


Supplemental Content

Loading ...
Support Center